Ophthalmology

The mission of the Department of Ophthalmology is to reduce vision-threatening eye diseases through clinical care, research, teaching, and community service. The goal is to provide the most effective and advanced management of ocular diseases and complex vision problems for the local, state, regional, national, and international communities.

UVA Ophthalmology is committed to excellence in education. We offer a fully accredited ophthalmic residency program, glaucoma and retina fellowship programs, and optometry residency program.  

The department offers comprehensive ophthalmic care as well as the following sub-specialties: anterior segment/cornea, glaucoma, neuro-ophthalmology, oculo-plastics, pediatric eye care, uveitis, refractive, medical and surgical retina, and optometry. UVA Ophthalmology prides itself in furthering knowledge of eye care through medical training and research.

COVID-19 Response

UVA Health’s COVID-19 Response

UVA Health’s Epidemiology and Emergency Management teams have together developed a response plan. Our goal is to protect the health of our patients and team members and quickly identify anyone who may need to be tested for the coronavirus. Click below for current information on testing and access information.
Learn More »

University of Virginia’s COVID-19 Response & Status

The University of Virginia is closely monitoring the emergence of COVID-19, and consulting with experts at UVA Health and other state and federal partners. Click below for School status, travel guidance and more.
Learn More »

LASIK & PRK

Laser vision correction at UVA LASIK offers clear, functional vision that may eliminate or reduce your dependence on glasses or contact lenses, help you feel better about how you look, and save you time every single day.

Ophthalmology Education Programs

The three-year residency program is designed to provide the resident with gradually increasing responsibility.
Learn More

Picture of doctor performing eye exam

Fellowships and Externship for Optometry Students

The Department of Ophthalmology at the University of Virginia offers a one-year clinical glaucoma fellowship and sponsors a two-year Vitreo-Retinal Fellowship.
Learn More

Picture of Dr. J. Ambati

Scientists Find Toxic Buildup in Eyes of Patients with Blinding Macular Degeneration

UVA’s Dr. Jayakrishna Ambati and his collaborators previously discovered that the harmful DNA, known as Alu cDNA, was manufactured in the cytoplasm. The new findings are believed to be the first time toxic Alu cDNA accumulation has been confirmed in patients in any disease.
Read More

COMMENTS OR QUESTIONS?

Have questions or comments? Please click here and fill out the contact form. Thank you!